LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $703 | +234.8% | 24,327 | +735.7% | 0.00% | +100.0% |
| Q2 2023 | $210 | -1.9% | 2,911 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $214 | +10.3% | 2,911 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $194 | -99.9% | 2,911 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $251,000 | -3.5% | 2,911 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $260,000 | -20.5% | 2,911 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $327,000 | -38.1% | 2,911 | -14.9% | 0.00% | -50.0% |
| Q4 2021 | $528,000 | +10.7% | 3,421 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $477,000 | +6.2% | 3,421 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $449,000 | -14.0% | 3,421 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $522,000 | +53.5% | 3,421 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $340,000 | +4.3% | 3,421 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $326,000 | -14.9% | 3,421 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $383,000 | +38.8% | 3,421 | -10.0% | 0.00% | 0.0% |
| Q1 2020 | $276,000 | -30.3% | 3,801 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $396,000 | +4.8% | 3,801 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $378,000 | -12.9% | 3,801 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $434,000 | -17.3% | 3,801 | -9.1% | 0.00% | 0.0% |
| Q1 2019 | $525,000 | -7.4% | 4,180 | 0.0% | 0.00% | -25.0% |
| Q4 2018 | $567,000 | -50.6% | 4,180 | 0.0% | 0.00% | -42.9% |
| Q3 2018 | $1,147,000 | +32.4% | 4,180 | 0.0% | 0.01% | +16.7% |
| Q2 2018 | $866,000 | +25.5% | 4,180 | 0.0% | 0.01% | +20.0% |
| Q1 2018 | $690,000 | +4.4% | 4,180 | -13.5% | 0.01% | +25.0% |
| Q4 2017 | $661,000 | +0.5% | 4,830 | 0.0% | 0.00% | -20.0% |
| Q3 2017 | $658,000 | +12.3% | 4,830 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $586,000 | +14.7% | 4,830 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $511,000 | +2.4% | 4,830 | -1.7% | 0.00% | 0.0% |
| Q4 2016 | $499,000 | -0.6% | 4,914 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $502,000 | -19.3% | 4,914 | -5.8% | 0.00% | -20.0% |
| Q2 2016 | $622,000 | -7.3% | 5,216 | -16.8% | 0.01% | -16.7% |
| Q1 2016 | $671,000 | -1.3% | 6,270 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $680,000 | +26.6% | 6,270 | 0.0% | 0.01% | +20.0% |
| Q3 2015 | $537,000 | -16.9% | 6,270 | -2.0% | 0.01% | 0.0% |
| Q2 2015 | $646,000 | -1.1% | 6,400 | -24.5% | 0.01% | 0.0% |
| Q1 2015 | $653,000 | +44.8% | 8,472 | 0.0% | 0.01% | +25.0% |
| Q4 2014 | $451,000 | +13.3% | 8,472 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $398,000 | -24.6% | 8,472 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $528,000 | -7.4% | 8,472 | 0.0% | 0.00% | -20.0% |
| Q1 2014 | $570,000 | +27.8% | 8,472 | 0.0% | 0.01% | +25.0% |
| Q4 2013 | $446,000 | +21.5% | 8,472 | 0.0% | 0.00% | +33.3% |
| Q3 2013 | $367,000 | +15.8% | 8,472 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $317,000 | – | 8,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |